HFSA/ACC/AHA, et al, (Accessed April 1, 2020), cited as Ref 23 in DOI: 10.1007/s11886-020-01293-2

From Wikibase.slis.ua.edu
Jump to navigation Jump to search

Bibliography entry in "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty" in Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34. DOI: https://doi.org/10.1007/s11886-020-01293-2


Information about this Cited Reference
TitleHFSA/ACC/AHA Joint Statement addressing concerns re: using RAAS antagonists in COVID-19.
URLhttps://www.hfsa.org/patients-taking-ace-i-and-arbs-who-contract-covid-19-should-continue-treatment-unless-otherwise-advised-by-their-physician/
1st AUHFSA/ACC/AHA
PubDate2020
Cited InCardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty (DOI: 10.1007/s11886-020-01293-2)
Retrieved from "http://wikibase.slis.ua.edu/w/index.php?title=HFSA/ACC/AHA,_et_al,_(Accessed_April_1,_2020),_cited_as_Ref_23_in_DOI:_10.1007/s11886-020-01293-2&oldid=221579"